EP1539819A2
Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 18 September 2023, 3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10441649B2 | Cited by | United States of America | Applicant |
| WO0136641A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO0193902A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO03078595A2 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| WO9622377A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO9954484A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
33 members in 10 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 412219P | United States of America | – | |
| 41221902 | United States of America | P | |
| PCTUS0307995 | World Intellectual Property Organization (WIPO) | – | |
| 0307995 | United States of America | W | |
| 0330188 | United States of America | W |
Members33
| Document | Office | Kind | |
|---|---|---|---|
| CA2479187A1 | Canada | A1 | |
| WO03078595A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003218181A1 | Australia | A1 | |
| WO03078595A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2499066A1 | Canada | A1 | |
| WO2004027049A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003276932A1 | Australia | A1 | |
| WO03078595B1 | World Intellectual Property Organization (WIPO) | B1 | |
| WO2004027049A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004027049B1 | World Intellectual Property Organization (WIPO) | B1 | |
| EP1485403A2 | European Patent Office (EPO) | A2 | |
| EP1539819A2This record | European Patent Office (EPO) | A2 | |
| JP2005526778A | Japan | A | |
| US2005222060A1 | United States of America | A1 | |
| CN1703427A | China | A | |
| JP2006514920A | Japan | A | |
| CN1780848A | China | A | |
| US2006193855A1 | United States of America | A1 | |
| HK1089773A | Hong Kong, China | A | |
| HK1089773A1 | Hong Kong, China | A1 | |
| US2007037769A1 | United States of America | A1 | |
| EP1485403A4 | European Patent Office (EPO) | A4 | |
| EP1539819A4 | European Patent Office (EPO) | A4 | |
| CN100376594C | China | C | |
| EP1539819B1 | European Patent Office (EPO) | B1 | |
| AT460944T | Austria | T | |
| ATE460944T1 | Austria | T1 | |
| DE60331741D1 | Germany | D1 | |
| EP2258712A2 | European Patent Office (EPO) | A2 | |
| EP2258712A3 | European Patent Office (EPO) | A3 | |
| US2011274705A1 | United States of America | A1 | |
| US2012189645A1 | United States of America | A1 | |
| US8809290B2 | United States of America | B2 |
66 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1539819
- Application
- 37979317
Titles3
- German
- VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ERSTELLUNG UND STEUERUNG DES EFFEKTORPROFILS VON T-ZELLEN DURCH GLEICHZEITIGES BELADEN UND AKTIVIEREN AUSGEWÄHLTER UNTERGRUPPEN VON ANTIGEN-PRÄSENTIERENDEN ZELLEN
- English
- METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF T CELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS
- French
- PROCEDES ET COMPOSITIONS POUR GENERER ET CONTROLER LE PROFIL EFFECTEUR DE LYMPHOCYTES T PAR LE CHARGEMENT ET L'ACTIVATION DE SOUS-ENSEMBLES SELECTIONNES DE CELLULES PRESENTANT L'ANTIGENE
Classification
- CPC, 34
- A61K31/7105
- A61K31/713
- A61K39/0011
- A61K39/12
- A61K39/145
- A61K39/21
- A61K39/39
- A61K45/06
- A61K2039/5252
- A61K2039/53
- A61K2039/544
- A61K2039/55511
- A61K2039/55561
- A61K2039/57
- C12N2710/20034
- C12N2740/16034
- C12N2760/16134
- A61K2039/545
- A61K2039/55566
- A61K39/385
- A61K2039/6056
- A61P31/14
- A61P31/16
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/04
- A61K39/001193
- A61K39/001182
- A61K39/00117
- A61K39/001191
- A61K39/001106
- A61K39/001156
- A61K39/001192
- IPC, 15
- A61K39 00
- A61K31 70
- A61K31 7105
- A61K31 713
- A61K39 12
- A61K39 145
- A61K39 21
- A61K39 385
- A61K39 39
- A61K39 395
- A61K48 00
- A61P37 04
- C07K16 00
- C12N5 10
- C12P21 08
Designated states31
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Albania
- Lithuania
- Latvia
- North Macedonia